Pharmacodynamics, Safety and Pharmacokinetics After Oral Administration of BIBR 1048 MS in Healthy Volunteers

NCT02170116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBR 1048 MS dose 1
DRUG: BIBR 1048 MS dose 2
DRUG: BIBR 1048 MS dose 3
DRUG: BIBR 1048 MS dose 4
DRUG: BIBR 1048 MS dose 5
DRUG: Placebo to BIBR 1048 MS

Sponsor

Boehringer Ingelheim